Andre Cassell
Overview
Explore the profile of Andre Cassell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
140
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capo-Lugo C, Shumock K, Young D, Klein L, Cassell A, Cvach M, et al.
J Nurs Manag
. 2019 Oct;
28(1):54-62.
PMID: 31605647
Aim: Characterize the relationship between patient ambulatory status and in-hospital call bell use. Background: Although call bells are frequently used by patients to request help, the relationship between physical functioning...
2.
Probasco J, Lavezza A, Cassell A, Shakes T, Feurer A, Russell H, et al.
Neurohospitalist
. 2018 Apr;
8(2):53-59.
PMID: 29623154
Background: Although many hospitalized neuroscience patients have physical and occupational therapy (rehabilitation) needs, patients with none or minimal physical impairments frequently receive rehabilitation consultation, diverting from patients with greatest need....
3.
Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models
Cassell A, Freilino M, Lee J, Barr S, Wang L, Panahandeh M, et al.
Neoplasia
. 2012 Dec;
14(11):1005-14.
PMID: 23226094
Head and neck squamous cell carcinoma (HNSCC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) where treatments targeting EGFR have met with limited clinical success. Elucidation of...
4.
Bhola N, Freilino M, Joyce S, Sen M, Thomas S, Sahu A, et al.
Mol Cancer Ther
. 2012 Apr;
11(6):1236-46.
PMID: 22491800
G-protein-coupled receptors (GPCR) activate the epidermal growth factor receptor (EGFR) and mediate EGFR-independent signaling pathways to promote the growth of a variety of cancers, including head and neck squamous cell...
5.
Cassell A, Grandis J
Expert Opin Investig Drugs
. 2010 Apr;
19(6):709-22.
PMID: 20415598
Importance Of The Field: EGFR is an established therapeutic target in head and neck squamous cell carcinoma (HNSCC). The EGFR-targeting monoclonal antibody cetuximab (Erbitux, Imclone Systems, Inc., Branchburg, USA) was...
6.
Whited J, Cassell A, Brouillette M, Garrity P
Development
. 2004 Aug;
131(19):4677-86.
PMID: 15329347
How a nucleus is positioned within a highly polarized postmitotic animal cell is not well understood. In this work, we demonstrate that the Dynactin complex (a regulator of the microtubule...